Month: March 2017

New Research Findings: Health Costs for Children With Cancer Are Higher Than for Adolescents, Adults

Substantial Survival Gains in Children Mean That Treatment May Still Be Highly Cost Effective   Princeton, NJ—March 21, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of original research estimating the costs of cancer care

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , ,

Introducing Novel Guidelines for Patient Engagement in Research

Using Real-World Examples to Inform the Integration of Patients as Full Research Partners in Outcomes Research   Princeton, NJ—March 20, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of suggested guidelines on establishing research partnerships with

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR Publishes New Task Force Report on Constrained Optimization Methods

Research Methodology Can Help Identify Best Approaches to Achieve Optimal Health Outcomes for Patients Princeton, NJ—March 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new task force report, Constrained Optimization Methods in Health Services Research—An Introduction:

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR Announces Plenary Sessions and Speakers For 22nd Annual International Meeting

Conference to Focus on Timely Theme of Evidence and Value in a Time of Social and Policy Change Princeton, NJ—March 6, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 22nd Annual International

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , ,

ISPOR’s COMMITMENT TO GLOBAL INCLUSIVITY AND SCIENTIFIC EXCELLENCE

ANNOUNCEMENT Princeton, NJ—March 2, 2017—“Science has no geographic boundaries,” said Nancy S. Berg, CEO and Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). “Scientific research and development is the basis for the rapid globalization of the

Posted in Announcements, ISPOR News & Press